ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/23/2023
Back to search
Official data from USPTO
ZECRUO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
07/23/2023
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
12/30/2020
Registration date
01/25/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2022
Last transaction
01/25/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
JAGANNATHAN, SIDDHARTH
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Theravance Biopharma Ireland Limited
Representatives
Beth H. Alter Seward & Kissel LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations and materialsdiagnostic preparations for medical and veterinary use; pharmaceutical preparations for treatment of human diseases of the autonomicrespiratoryendocrinecirculatorygastrointestinalgenito-urinaryintegumentaryimmune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and lightheadedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of bacterial and viral infectionsnamely anti-infectives
Publications
History of USPTO decisions and trademark events.
22 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/01/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/07/2022
FIMP
FINAL DISPOSITION PROCESSED
07/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/25/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/25/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2021
RFNT
REFUSAL PROCESSED BY IB
08/15/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/28/2021
RFRR
REFUSAL PROCESSED BY MPU
07/28/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/19/2021
CNRT
NON-FINAL ACTION WRITTEN
07/18/2021
DOCK
ASSIGNED TO EXAMINER
07/03/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/04/2021
Continuous trademark protection
Get notified about every new filing that threatens ZECRUO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.